Purdue Pharma executives pushed to get patients on higher and higher doses of OxyContin -- including a super-potent version nicknamed "Oxy-Coffin'' -- despite knowing the dangers, new court papers allege. In 2008, Richard Sackler -- a former Purdue president whose family owns the pharma giant -- directed management to "measure our performance by Rx's by...